Efficacy and Safety of Odevixibat in Patients With Alagille Syndrome
Summary
- Location
- at San Francisco, California and other locations
- Dates
- study startedestimated completion
- Principal Investigator
- by Philip Rosenthal
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Lead Scientist at UCSF
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Albireo
- ID
- NCT04674761
- Phase
- Phase 3
- Study Type
- Interventional
- Last Updated